Cargando…
Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats
Wound healing in diabetes is frequently impaired, and its treatment remains a challenge. We tested a therapeutic strategy of potentiating intrinsic tissue regeneration by restoring the wound cellular environment using a heparan sulfate glycosaminoglycan mimetic, OTR4120. The effect of OTR4120 on hea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447910/ https://www.ncbi.nlm.nih.gov/pubmed/22721969 http://dx.doi.org/10.2337/db11-1329 |
_version_ | 1782244192856047616 |
---|---|
author | Tong, Miao Tuk, Bastiaan Shang, Peng Hekking, Ineke M. Fijneman, Esther M.G. Guijt, Marnix Hovius, Steven E.R. van Neck, Johan W. |
author_facet | Tong, Miao Tuk, Bastiaan Shang, Peng Hekking, Ineke M. Fijneman, Esther M.G. Guijt, Marnix Hovius, Steven E.R. van Neck, Johan W. |
author_sort | Tong, Miao |
collection | PubMed |
description | Wound healing in diabetes is frequently impaired, and its treatment remains a challenge. We tested a therapeutic strategy of potentiating intrinsic tissue regeneration by restoring the wound cellular environment using a heparan sulfate glycosaminoglycan mimetic, OTR4120. The effect of OTR4120 on healing of diabetic ulcers was investigated. Experimental diabetes was induced by intraperitoneal injection of streptozotocin. Seven weeks after induction of diabetes, rats were ulcerated by clamping a pair of magnet disks on the dorsal skin for 16 h. After magnet removal, OTR4120 was administered via an intramuscular injection weekly for up to 4 weeks. To examine the effect of OTR4120 treatment on wound heal-ing, the degree of ulceration, inflammation, angiogenesis, and collagen synthesis were evaluated. We found that OTR4120 treatment significantly reduced the degree of ulceration and the time of healing. These effects were associated with reduced neutrophil infiltration and macrophage accumulation and enhanced angiogenesis. OTR4120 treatment also increased the collagen content with an increase of collagen type I biosynthesis and reduction of collagen type III biosynthesis. Moreover, restoration of the ulcer biomechanical strength was significantly enhanced after OTR4120 treatment. This study shows that matrix therapy with OTR4120 improves diabetes-impaired wound healing. |
format | Online Article Text |
id | pubmed-3447910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-34479102013-10-01 Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats Tong, Miao Tuk, Bastiaan Shang, Peng Hekking, Ineke M. Fijneman, Esther M.G. Guijt, Marnix Hovius, Steven E.R. van Neck, Johan W. Diabetes Pharmacology and Therapeutics Wound healing in diabetes is frequently impaired, and its treatment remains a challenge. We tested a therapeutic strategy of potentiating intrinsic tissue regeneration by restoring the wound cellular environment using a heparan sulfate glycosaminoglycan mimetic, OTR4120. The effect of OTR4120 on healing of diabetic ulcers was investigated. Experimental diabetes was induced by intraperitoneal injection of streptozotocin. Seven weeks after induction of diabetes, rats were ulcerated by clamping a pair of magnet disks on the dorsal skin for 16 h. After magnet removal, OTR4120 was administered via an intramuscular injection weekly for up to 4 weeks. To examine the effect of OTR4120 treatment on wound heal-ing, the degree of ulceration, inflammation, angiogenesis, and collagen synthesis were evaluated. We found that OTR4120 treatment significantly reduced the degree of ulceration and the time of healing. These effects were associated with reduced neutrophil infiltration and macrophage accumulation and enhanced angiogenesis. OTR4120 treatment also increased the collagen content with an increase of collagen type I biosynthesis and reduction of collagen type III biosynthesis. Moreover, restoration of the ulcer biomechanical strength was significantly enhanced after OTR4120 treatment. This study shows that matrix therapy with OTR4120 improves diabetes-impaired wound healing. American Diabetes Association 2012-10 2012-09-13 /pmc/articles/PMC3447910/ /pubmed/22721969 http://dx.doi.org/10.2337/db11-1329 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Pharmacology and Therapeutics Tong, Miao Tuk, Bastiaan Shang, Peng Hekking, Ineke M. Fijneman, Esther M.G. Guijt, Marnix Hovius, Steven E.R. van Neck, Johan W. Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title | Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title_full | Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title_fullStr | Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title_full_unstemmed | Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title_short | Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats |
title_sort | diabetes-impaired wound healing is improved by matrix therapy with heparan sulfate glycosaminoglycan mimetic otr4120 in rats |
topic | Pharmacology and Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447910/ https://www.ncbi.nlm.nih.gov/pubmed/22721969 http://dx.doi.org/10.2337/db11-1329 |
work_keys_str_mv | AT tongmiao diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT tukbastiaan diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT shangpeng diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT hekkinginekem diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT fijnemanesthermg diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT guijtmarnix diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT hoviusstevener diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats AT vanneckjohanw diabetesimpairedwoundhealingisimprovedbymatrixtherapywithheparansulfateglycosaminoglycanmimeticotr4120inrats |